fluoxetine has been researched along with Premenstrual Tension in 76 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Premenstrual Tension: A term used to describe the psychological aspects of PREMENSTRUAL SYNDROME, such as the indescribable tension, depression, hostility, and increased seizure activity in women with seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The neuroactive metabolite of progesterone, allopregnanolone (ALLO), has been implicated in premenstrual syndrome (PMS) physiopathology and preclinical studies suggested that low doses of fluoxetine increase the ALLO brain concentration." | 9.69 | Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study. ( Brandão, ML; de Rezende, MG; Del-Ben, CM; Graeff, FG; Guapo, VG; Lovick, T; Maranho, MCMF; Vieira, CS, 2023) |
| "To compare efficacy of combined use of fluoxetine and combined oral contraceptives (COC) versus COC alone in treating severe premenstrual syndrome (PMS), a randomized double-blind placebo-controlled three-arm trial was conducted at Cairo and Beni-Suef University Hospitals." | 9.34 | Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial. ( El Wahed, HAA; Fahim, AS; Hussein, GK; Katta, MA; Moety, GAFA; Shehata, NAA, 2020) |
| "The dietary technique of acute tryptophan depletion was used to suppress brain serotonin synthesis in 16 women with documented premenstrual syndrome." | 9.07 | Acute tryptophan depletion aggravates premenstrual syndrome. ( Coates, DC; Fawcett, JP; Menkes, DB, 1994) |
| "This study extends our previous report of the efficacy and tolerability of fluoxetine in severe premenstrual syndrome (PMS), describes which aspects of the disorder are responsive to such treatment, and assesses the relationship between steady-state drug level and clinical outcome." | 9.07 | Fluoxetine's spectrum of action in premenstrual syndrome. ( Howard, RC; Mason, PA; Menkes, DB; Taghavi, E, 1993) |
| "To assess the possible efficacy of fluoxetine hydrochloride in severe PMS (premenstrual syndrome, luteal phase dysphoric disorder), an open trial of this medication was undertaken on women with severe PMS." | 9.07 | Open trial of fluoxetine therapy for premenstrual syndrome. ( Elks, ML, 1993) |
| "Fluoxetine is an effective and well-tolerated drug and appears to have considerable promise in treating a range of symptoms in women with PMS." | 6.68 | Fluoxetine in the treatment of premenstrual syndrome. ( Corakçi, A; Erhan, G; Mercan, R; Ozeren, S; Yücesoy, I, 1997) |
| "Fluoxetine appears to be a highly effective, well-tolerated treatment for the psychological and physical symptoms accompanying severe PMS." | 6.67 | Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. ( Chan, YF; Moossazadeh, F; Mortola, JF; Wood, SH; Yen, SS, 1992) |
| "The neuroactive metabolite of progesterone, allopregnanolone (ALLO), has been implicated in premenstrual syndrome (PMS) physiopathology and preclinical studies suggested that low doses of fluoxetine increase the ALLO brain concentration." | 5.69 | Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study. ( Brandão, ML; de Rezende, MG; Del-Ben, CM; Graeff, FG; Guapo, VG; Lovick, T; Maranho, MCMF; Vieira, CS, 2023) |
| "To compare efficacy of combined use of fluoxetine and combined oral contraceptives (COC) versus COC alone in treating severe premenstrual syndrome (PMS), a randomized double-blind placebo-controlled three-arm trial was conducted at Cairo and Beni-Suef University Hospitals." | 5.34 | Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial. ( El Wahed, HAA; Fahim, AS; Hussein, GK; Katta, MA; Moety, GAFA; Shehata, NAA, 2020) |
| "Fluoxetine in 10-mg doses presented the best results for treating premenstrual syndrome." | 5.08 | A double-blind trial of four medications to treat severe premenstrual syndrome. ( da Fonseca, AM; Diegoli, CA; Diegoli, MS; Pinotti, JA, 1998) |
| "The dietary technique of acute tryptophan depletion was used to suppress brain serotonin synthesis in 16 women with documented premenstrual syndrome." | 5.07 | Acute tryptophan depletion aggravates premenstrual syndrome. ( Coates, DC; Fawcett, JP; Menkes, DB, 1994) |
| "This study extends our previous report of the efficacy and tolerability of fluoxetine in severe premenstrual syndrome (PMS), describes which aspects of the disorder are responsive to such treatment, and assesses the relationship between steady-state drug level and clinical outcome." | 5.07 | Fluoxetine's spectrum of action in premenstrual syndrome. ( Howard, RC; Mason, PA; Menkes, DB; Taghavi, E, 1993) |
| "To assess the possible efficacy of fluoxetine hydrochloride in severe PMS (premenstrual syndrome, luteal phase dysphoric disorder), an open trial of this medication was undertaken on women with severe PMS." | 5.07 | Open trial of fluoxetine therapy for premenstrual syndrome. ( Elks, ML, 1993) |
| " Search terms included fluoxetine, premenstrual dysphoric disorder, PMDD, late luteal-phase dysphoric disorder, and severe premenstrual syndrome." | 4.81 | Fluoxetine in the treatment of premenstrual dysphoric disorder. ( Carr, RR; Ensom, MH, 2002) |
| "The largest number of antidepressant treatment trials in premenstrual syndrome and premenstrual dysphoric disorder (PMDD) have been conducted with fluoxetine." | 4.81 | Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder. ( Pearlstein, T; Yonkers, KA, 2002) |
| "Fluoxetine treatment had a more rapid effect and greater impact upon anxiety symptoms, while CBT was associated with increased use of cognitive and behavioural coping strategies and a shift from a biomedical to a biopsychosocial causal attribution of premenstrual symptoms." | 2.70 | Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes. ( Browne, S; Cariss, M; Hunter, MS; Jelley, R; Katz, M; Ussher, JM, 2002) |
| "Premenstrual daily dosing with fluoxetine effectively treats mood, physical, and social functioning symptoms associated with premenstrual dysphoric disorder." | 2.70 | Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. ( Brown, EW; Cohen, LS; Freeman, E; Halbreich, U; McCray, S; Miner, C; Sundell, K, 2002) |
| "Fluoxetine was associated with a more rapid improvement." | 2.70 | A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. ( Browne, SJ; Cariss, M; Hunter, MS; Jelley, R; Katz, M; Ussher, JM, 2002) |
| "Fluoxetine treatment was statistically superior to placebo, with no significant differences between the two fluoxetine dosages in their effects on physical symptoms." | 2.70 | The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. ( Babcock, S; Berger, C; Carter, D; Dillon, J; Judge, R; Reid, R; Romano, SJ; Shuler, C; Steinberg, S; Steiner, M; Stewart, D, 2001) |
| "Because the symptoms of premenstrual dysphoric disorder (PMDD) are limited to the luteal phase of the menstrual cycle, the potential benefit of luteal-phase dosing has been hypothesized." | 2.70 | Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial. ( Brown, E; Gonzales, J; McCray, S; Miner, C; Wohlreich, M, 2002) |
| "Treatment with fluoxetine at a dose of 20 mg per day reduces the potential for side effects while maximizing therapeutic efficacy." | 2.68 | Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. ( Berger, C; Carter, D; Grover, D; Reid, R; Steinberg, S; Steiner, M; Stewart, D; Streiner, D, 1995) |
| "Fluoxetine is an effective and well-tolerated drug and appears to have considerable promise in treating a range of symptoms in women with PMS." | 2.68 | Fluoxetine in the treatment of premenstrual syndrome. ( Corakçi, A; Erhan, G; Mercan, R; Ozeren, S; Yücesoy, I, 1997) |
| "Fluoxetine was superior to both bupropion and placebo." | 2.68 | Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. ( Brown, WA; Lund, SA; Pearlstein, TB; Scheft, H; Stone, AB; Zlotnick, C, 1997) |
| "7%) in the continuous dosing group and 18 women (75." | 2.68 | Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. ( Korzekwa, M; Lamont, J; Steiner, M; Wilkins, A, 1997) |
| "Fluoxetine is an effective and well-tolerated treatment for this condition when used over time." | 2.67 | Long-term fluoxetine treatment of late luteal phase dysphoric disorder. ( Pearlstein, TB; Stone, AB, 1994) |
| "Fluoxetine appears to be a highly effective, well-tolerated treatment for the psychological and physical symptoms accompanying severe PMS." | 2.67 | Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. ( Chan, YF; Moossazadeh, F; Mortola, JF; Wood, SH; Yen, SS, 1992) |
| "Selective serotonin reuptake inhibitors were found to be effective in treating premenstrual symptoms, with continuous dosing regimens favored for effectiveness." | 2.44 | Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. ( Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R, 2008) |
| "Fluoxetine 20 mg/d is an effective and well-tolerated treatment for women with PMDD, a severe variant of PMS." | 2.40 | The role of fluoxetine in the treatment of premenstrual dysphoric disorder. ( Dillon, J; Judge, R; Romano, S; Shuler, C; Sundell, K, 1999) |
| "The rapid recurrence of symptoms further supports the view of premenstrual dysphoric disorder as a clinical entity distinct from depression." | 1.32 | Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. ( Brown, EB; Joliat, MJ; Miner, CM; Pearlstein, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.32) | 18.7374 |
| 1990's | 31 (40.79) | 18.2507 |
| 2000's | 35 (46.05) | 29.6817 |
| 2010's | 7 (9.21) | 24.3611 |
| 2020's | 2 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Maranho, MCMF | 1 |
| Guapo, VG | 1 |
| de Rezende, MG | 1 |
| Vieira, CS | 1 |
| Brandão, ML | 1 |
| Graeff, FG | 1 |
| Lovick, T | 2 |
| Del-Ben, CM | 1 |
| Shehata, NAA | 1 |
| Moety, GAFA | 1 |
| El Wahed, HAA | 1 |
| Fahim, AS | 1 |
| Katta, MA | 1 |
| Hussein, GK | 1 |
| Yonkers, KA | 3 |
| Pearlstein, TB | 5 |
| Gotman, N | 1 |
| Gao, X | 1 |
| Sun, P | 1 |
| Qiao, M | 1 |
| Wei, S | 1 |
| Xue, L | 1 |
| Zhang, H | 1 |
| Schneider, T | 2 |
| Popik, P | 2 |
| Rendas-Baum, R | 1 |
| Yang, M | 1 |
| Gricar, J | 1 |
| Wallenstein, GV | 1 |
| Shchepotin, IB | 1 |
| Zotov, AS | 1 |
| Dobzhenko, MN | 1 |
| Steinberg, EM | 1 |
| Cardoso, GM | 1 |
| Martinez, PE | 1 |
| Rubinow, DR | 4 |
| Schmidt, PJ | 4 |
| Nazari, H | 1 |
| Yari, F | 1 |
| Jariani, M | 1 |
| Marzban, A | 1 |
| Birgandy, M | 1 |
| Hunter, MS | 2 |
| Ussher, JM | 2 |
| Cariss, M | 2 |
| Browne, S | 1 |
| Jelley, R | 2 |
| Katz, M | 2 |
| Cohen, LS | 2 |
| Miner, C | 2 |
| Brown, EW | 1 |
| Freeman, E | 1 |
| Halbreich, U | 1 |
| Sundell, K | 2 |
| McCray, S | 2 |
| Hendrick, V | 1 |
| Altshuler, L | 1 |
| Roca, CA | 1 |
| Smith, MJ | 1 |
| Danaceau, MA | 2 |
| Murphy, DL | 2 |
| Browne, SJ | 1 |
| Oláh, KS | 1 |
| Atmaca, M | 1 |
| Kumru, S | 1 |
| Tezcan, E | 1 |
| Pearlstein, T | 3 |
| Joliat, MJ | 1 |
| Brown, EB | 1 |
| Miner, CM | 1 |
| Steiner, M | 8 |
| Brown, E | 2 |
| Trzepacz, P | 1 |
| Dillon, J | 3 |
| Berger, C | 4 |
| Carter, D | 4 |
| Reid, R | 5 |
| Stewart, D | 5 |
| Domoney, CL | 1 |
| Vashisht, A | 1 |
| Studd, JW | 1 |
| Moynihan, R | 1 |
| Greenslit, N | 2 |
| Tamayo, JM | 1 |
| Gómez, G | 1 |
| Barrios, R | 1 |
| Holguín, J | 1 |
| Adrianzén, C | 1 |
| Silber, TJ | 1 |
| Valadez-Meltzer, A | 1 |
| Labad, J | 1 |
| Menchón, JM | 1 |
| Alonso, P | 1 |
| Segalàs, C | 1 |
| Jiménez, S | 1 |
| Vallejo, J | 1 |
| Nur, MM | 1 |
| Romano, ME | 1 |
| Siqueira, LM | 1 |
| Shah, NR | 1 |
| Jones, JB | 1 |
| Aperi, J | 1 |
| Shemtov, R | 1 |
| Karne, A | 1 |
| Borenstein, J | 1 |
| van Leusden, HA | 1 |
| Prior, JC | 1 |
| Gill, K | 1 |
| Vigna, YM | 1 |
| Edbril, SD | 1 |
| Steinberg, S | 4 |
| Grover, D | 2 |
| Streiner, D | 2 |
| Menkes, DB | 3 |
| Coates, DC | 1 |
| Fawcett, JP | 1 |
| Altshuler, LL | 1 |
| Stewart, DE | 1 |
| Fairman, M | 1 |
| Barbadoro, S | 1 |
| Zownir, P | 1 |
| Mortola, JF | 2 |
| Stone, AB | 4 |
| Brandenburg, S | 1 |
| Tuynman-Qua, H | 1 |
| Verheij, R | 1 |
| Pepplinkhuizen, L | 1 |
| Taghavi, E | 2 |
| Mason, PA | 2 |
| Howard, RC | 2 |
| Elks, ML | 1 |
| Su, TP | 1 |
| Tobin, MB | 1 |
| Rosenstein, DL | 1 |
| Ozeren, S | 1 |
| Corakçi, A | 1 |
| Yücesoy, I | 1 |
| Mercan, R | 1 |
| Erhan, G | 1 |
| Lund, SA | 1 |
| Scheft, H | 1 |
| Zlotnick, C | 1 |
| Brown, WA | 4 |
| Lamont, J | 2 |
| Nelson, EB | 1 |
| Keck, PE | 1 |
| McElroy, SL | 1 |
| Korzekwa, M | 1 |
| Wilkins, A | 1 |
| Diegoli, MS | 1 |
| da Fonseca, AM | 1 |
| Diegoli, CA | 1 |
| Pinotti, JA | 1 |
| Romano, S | 1 |
| Judge, R | 2 |
| Shuler, C | 2 |
| Streiner, DL | 1 |
| Henney, JE | 1 |
| Ho, HP | 1 |
| Olsson, M | 1 |
| Westberg, L | 1 |
| Melke, J | 1 |
| Eriksson, E | 1 |
| Romano, SJ | 1 |
| Babcock, S | 1 |
| Parry, BL | 1 |
| Newton, RP | 1 |
| Lin, J | 1 |
| Thompson, DS | 1 |
| Carr, M | 1 |
| Carr, RR | 1 |
| Ensom, MH | 1 |
| Gonzales, J | 1 |
| Wohlreich, M | 1 |
| Gupta, S | 1 |
| Spears, GF | 1 |
| Wood, SH | 1 |
| Chan, YF | 1 |
| Moossazadeh, F | 1 |
| Yen, SS | 1 |
| Daamen, MJ | 1 |
| Metz, A | 1 |
| Pies, RW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Development and Evaluation of an Internet-based Cognitive Behaviour Therapy for Women With Premenstrual Syndrome (PMS)[NCT01961479] | 174 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Does Adding Combined Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome? A Double Blind Placebo Controlled Study.[NCT02562053] | Phase 3 | 300 participants (Anticipated) | Interventional | 2015-10-31 | Recruiting | ||
| Comparative Effects of Aerobic Exercises and Yoga on Pain and Symptoms Severity in Premenstrual Syndrome[NCT05834127] | 36 participants (Actual) | Interventional | 2022-11-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for fluoxetine and Premenstrual Tension
| Article | Year |
|---|---|
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; F | 2010 |
SSRIs for premenstrual dysphoric disorder.
Topics: Female; Fluoxetine; Humans; Premenstrual Syndrome; Randomized Controlled Trials as Topic; Selective | 2002 |
Management strategies for PMS/PMDD.
Topics: Contraceptives, Oral; Female; Fluoxetine; Gonadotropin-Releasing Hormone; Humans; Premenstrual Syndr | 2004 |
Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
Topics: Adolescent; Clinical Trials as Topic; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective S | 2005 |
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syn | 2008 |
A risk-benefit appraisal of drugs used in the management of premenstrual syndrome.
Topics: Benzodiazepines; Contraceptives, Oral; Female; Fluoxetine; Gonadotropin-Releasing Hormone; Humans; P | 1994 |
The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Female; Fluoxetine; Humans; Prem | 1999 |
Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
Topics: Diagnosis, Differential; Female; Fluoxetine; Humans; Premenstrual Syndrome; Psychiatric Status Ratin | 2000 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, P | 2001 |
Treating premenstrual dysphoric disorder using serotonin agents.
Topics: Female; Fluoxetine; Humans; Mood Disorders; Premenstrual Syndrome; Selective Serotonin Reuptake Inhi | 2001 |
Fluoxetine in the treatment of premenstrual dysphoric disorder.
Topics: Adolescent; Female; Fluoxetine; Humans; MEDLINE; Middle Aged; Premenstrual Syndrome; Randomized Cont | 2002 |
Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
Topics: Antidepressive Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Fe | 2002 |
30 trials available for fluoxetine and Premenstrual Tension
| Article | Year |
|---|---|
Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Humans; Menstrual Cycle; Pilot Projects; Pregnanolon | 2023 |
Does Adding Fluoxetine to Combined Oral Contraceptives Containing Drospirenone Improve the Management of Severe Premenstrual Syndrome? A 6-Month Randomized Double-Blind Placebo-Controlled Three-Arm Trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Double-Blind Met | 2020 |
A pilot study to compare fluoxetine, calcium, and placebo in the treatment of premenstrual syndrome.
Topics: Adult; Calcium; Connecticut; Dietary Supplements; Double-Blind Method; Female; Fluoxetine; Humans; M | 2013 |
Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine.
Topics: Adolescent; Adult; Buspirone; Female; Fluoxetine; Humans; Middle Aged; Premenstrual Syndrome; Select | 2013 |
Medical (fluoxetine) and psychological (cognitive-behavioural therapy) treatment for premenstrual dysphoric disorder: a study of treatment processes.
Topics: Adaptation, Psychological; Administration, Oral; Adult; Anxiety Disorders; Cognitive Behavioral Ther | 2002 |
Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
Topics: Diagnosis, Computer-Assisted; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administra | 2002 |
Effects of metergoline on symptoms in women with premenstrual dysphoric disorder.
Topics: Adult; Affect; Depression; Diphenhydramine; Double-Blind Method; Female; Fluoxetine; Humans; Metergo | 2002 |
A randomized comparison of psychological (cognitive behavior therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder.
Topics: Adult; Analysis of Variance; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxe | 2002 |
Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Middle Aged | 2003 |
Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Mi | 2003 |
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Topics: Adolescent; Adult; Depression; Double-Blind Method; Female; Fluoxetine; Humans; Middle Aged; Premens | 1995 |
Acute tryptophan depletion aggravates premenstrual syndrome.
Topics: Adult; Amino Acids; Brain; Contraceptives, Oral; Double-Blind Method; Female; Fluoxetine; Humans; Mi | 1994 |
Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Follicular Phase; Humans; Luteal Phase; Middle Aged; | 1994 |
Long-term fluoxetine treatment of late luteal phase dysphoric disorder.
Topics: Adult; Age of Onset; Comorbidity; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Humans | 1994 |
Fluoxetine's spectrum of action in premenstrual syndrome.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Luteal Phase; Personali | 1993 |
Open trial of fluoxetine therapy for premenstrual syndrome.
Topics: Adult; Depression; Female; Fluoxetine; Humans; Premenstrual Syndrome | 1993 |
Fluoxetine in the treatment of premenstrual dysphoria.
Topics: Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Fluoxetine; Humans; Mi | 1997 |
Fluoxetine in the treatment of premenstrual syndrome.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Half-Life; Humans; Premenstrual Syndrome; Selective | 1997 |
Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Bupropion; Double-Blind Method; Female; | 1997 |
Effect of fluoxetine on menstrual cycle length in women with premenstrual dysphoria.
Topics: Adult; Female; Fluoxetine; Humans; Menstrual Cycle; Middle Aged; Mood Disorders; Premenstrual Syndro | 1997 |
Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria.
Topics: Adult; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors | 1997 |
A double-blind trial of four medications to treat severe premenstrual syndrome.
Topics: Alprazolam; Anti-Anxiety Agents; Double-Blind Method; Female; Fluoxetine; Humans; Premenstrual Syndr | 1998 |
The measurement of premenstrual mood symptoms.
Topics: Double-Blind Method; Female; Fluoxetine; Humans; Premenstrual Syndrome; Psychological Tests; Selecti | 1999 |
The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder.
Topics: Adult; Analysis of Variance; Double-Blind Method; Female; Fluoxetine; Humans; Premenstrual Syndrome; | 2001 |
Chronobiological basis of female-specific mood disorders.
Topics: Antidepressive Agents, Second-Generation; Chronobiology Phenomena; Cross-Over Studies; Depression, P | 2001 |
Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Fluoxetine | 2002 |
Fluoxetine treatment of severe premenstrual syndrome.
Topics: Adolescent; Adult; Double-Blind Method; Female; Fluoxetine; Humans; Middle Aged; Premenstrual Syndro | 1992 |
Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Humans; MMPI; Premenstrual Syndrome; Psychiatric Sta | 1992 |
Fluoxetine in the treatment of late luteal phase dysphoric disorder.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Humans; Middle Aged; Placebos; Premenstrual Syndrome | 1991 |
Fluoxetine in the treatment of premenstrual syndrome.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Humans; Premenstrual Syndrome; Psychiatric Status Ra | 1990 |
35 other studies available for fluoxetine and Premenstrual Tension
| Article | Year |
|---|---|
SSRIs and the female brain--potential for utilizing steroid-stimulating properties to treat menstrual cycle-linked dysphorias.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Epilepsy; Female; Fluoxetine; GABAergic Neurons; H | 2013 |
Shu‑Yu capsule, a Traditional Chinese Medicine formulation, attenuates premenstrual syndrome depression induced by chronic stress constraint.
Topics: Animals; Body Mass Index; Depression; Drugs, Chinese Herbal; Female; Fluoxetine; gamma-Aminobutyric | 2014 |
An animal model of premenstrual dysphoric disorder sensitive to antidepressants.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Disease Models, Animal; Estrous Cycle; Female; Flu | 2009 |
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineral | 2010 |
Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
Topics: Adult; Analysis of Variance; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F | 2012 |
Management of major depression during pregnancy.
Topics: Adult; Antidepressive Agents; Behavior Therapy; Depressive Disorder; Female; Fluoxetine; Humans; Pre | 2002 |
The use of fluoxetine (Prozac) in premenstrual syndrome: is the incidence of sexual dysfunction and anorgasmia acceptable?
Topics: Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Middle Aged; Premenstru | 2002 |
Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Administration Schedule; Female; Fluoxetine; H | 2003 |
Use of complementary therapies by women attending a specialist premenstrual syndrome clinic.
Topics: Adult; Complementary Therapies; Estradiol; Female; Fluoxetine; Humans; Middle Aged; Patient Satisfac | 2003 |
Controversial disease dropped from Prozac product information.
Topics: Antidepressive Agents, Second-Generation; Drug Industry; Drug Labeling; Europe; Female; Fluoxetine; | 2004 |
Pharmaceutical branding: identity, individuality, and illness.
Topics: Advertising; Depression; Drug Industry; Female; Fluoxetine; Humans; Individuality; Marketing; Patien | 2002 |
Differential time course efficacy on dysphoric and physical symptoms of the intermittent dosing of fluoxetine in the premenstrual dysphoric disorder.
Topics: Adult; Depressive Disorder; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Hum | 2004 |
Depression and consumption: psychopharmaceuticals, branding, and new identity practices.
Topics: Adult; Attitude to Health; Depression; Female; Fluoxetine; Health Behavior; Humans; Physician-Patien | 2005 |
Oral contraceptive pill use and changes in obsessive-compulsive symptoms.
Topics: Adult; Clomipramine; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Female; Fluoxetine; | 2006 |
Premenstrual dysphoric disorder in an adolescent female.
Topics: Adolescent; Depressive Disorder; Female; Fluoxetine; Humans; Luteal Phase; Premenstrual Syndrome; Se | 2007 |
Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Desipramine; Estrous Cycle; Female; Fluoxetine; Mo | 2007 |
Premenstrual syndrome no progesterone; premenstrual dysphoric disorder no serotonin deficiency.
Topics: Affect; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Female; Fluoxetin | 1995 |
Fluoxetine for premenstrual dysphoria.
Topics: Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors | 1995 |
Fluoxetine for premenstrual dysphoria.
Topics: Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Testoste | 1995 |
The treatment of premenstrual syndrome--forward into the past.
Topics: Adult; Female; Fluoxetine; Humans; Mood Disorders; Premenstrual Syndrome; Serotonin | 1995 |
Fluoxetine-associated panic attacks.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; Humans; Panic; Premenstrual Syndrome; Recurrence; Su | 1994 |
Treatment of premenstrual syndrome with fluoxetine: an open study.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Personality Inventory; Pr | 1993 |
Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron.
Topics: Drug Administration Schedule; Female; Fluoxetine; Granisetron; Humans; Middle Aged; Premenstrual Syn | 1997 |
Sertraline for premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Premenstrua | 1998 |
From the Food and Drug Administration.
Topics: Administration, Oral; Antiviral Agents; Cyclosporine; Drug and Narcotic Control; Drug Labeling; Fluo | 2000 |
Old drug, new label.
Topics: Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Dru | 2001 |
The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?
Topics: Aggression; Animals; Behavior, Animal; Brain; Disease Models, Animal; Estradiol; Estrus; Female; Flu | 2001 |
Selections from current literature. Treatments for premenstrual dysphoric disorder.
Topics: Affective Symptoms; Antidepressive Agents; Calcium; Female; Fluoxetine; Humans; Luteal Phase; Phytot | 2001 |
Beyond premenstrual syndrome.
Topics: Adult; Antidepressive Agents; Drug Approval; Female; Fluoxetine; Humans; Premenstrual Syndrome; Sele | 2002 |
Single-dose fluoxetine in management of premenstrual syndrome.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Nortriptyl | 1992 |
Fluoxetine and preoccupation with suicide.
Topics: Adolescent; Adult; Antipsychotic Agents; Drug Interactions; Female; Fluoxetine; Humans; Middle Aged; | 1991 |
Fluoxetine treatment of premenstrual syndrome.
Topics: Adult; Depression; Depressive Disorder; Female; Fluoxetine; Humans; Premenstrual Syndrome | 1990 |
Fluoxetine treatment of premenstrual syndrome.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; P | 1990 |
Premenstrual syndrome treatments.
Topics: Adult; Depressive Disorder; Female; Fluoxetine; Humans; Nortriptyline; Premenstrual Syndrome | 1989 |